Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Kumar Chidambaram

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
BMC Infectious Diseases|April 16, 2022
The role of procalcitonin in predicting risk of mechanical ventilation and mortality among moderate to severe COVID-19 patientsCher Wei Twe, Delton Kah Yeang Khoo, Kian Boon Law, et al.
Journal of Pharmaceutical Policy and Practice|May 25, 2026
Landscape of national antibiotic utilisation in Malaysia: an analysis of national pharmaceutical sales data from 2019 to 2023Audrey Huili Lim, Norazida Ab Rahman, Siti Nur Su'Aidah Nasarudin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 11, 2023
Real-world nirmatrelvir-ritonavir outpatient treatment in reducing hospitalization for high-risk patients with COVID-19 during Omicron BA.4, BA.5 and XBB subvariants dominance in Malaysia: A retrospective cohort studyEe Vien Low, Mohan Dass Pathmanathan, Suresh Kumar Chidambaram, et al.
International Journal of Environmental Research and Public Health|March 11, 2023
Stigma, Sociodemographic Factors, and Clinical Factors Associated with Psychological Distress among COVID-19 Survivors during the Convalescence Period: A Multi-Centre Study in MalaysiaNur Iwana Abdul Taib, Nik Ruzyanei Nik Jaafar, Nazirah Azman, et al.
Drugs - Real World Outcomes|May 10, 2024
Economic Evaluation of Nirmatrelvir/Ritonavir Among Adults Against Hospitalization During the Omicron Dominated Period in Malaysia: A Real-World Evidence PerspectiveEe Vien Low, Hoon Shien Teh, Nicholas Yee Liang Hing, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open-Label Clinical TrialChuan Huan Chuah, Ting Soo Chow, Chee Peng Hor, et al.
The Lancet Regional Health. Western Pacific|March 29, 2021
Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in MalaysiaYuan Liang Woon, Yee Leng Lee, Yoong Min Chong, et al.
Travel Medicine and Infectious Disease|July 24, 2021
Diagnostic accuracy of fresh drooled saliva for SARS-CoV-2 in travelersAlif Adlan Mohd Thabit, Kalaiarasu M Peariasamy, Pei Xuan Kuan, et al.
JAMA Internal Medicine|February 18, 2022
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical TrialSteven Chee Loon Lim, Chee Peng Hor, Kim Heng Tay, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
BMC Infectious Diseases|April 16, 2022
The role of procalcitonin in predicting risk of mechanical ventilation and mortality among moderate to severe COVID-19 patientsCher Wei Twe, Delton Kah Yeang Khoo, Kian Boon Law, et al.
Journal of Pharmaceutical Policy and Practice|May 25, 2026
Landscape of national antibiotic utilisation in Malaysia: an analysis of national pharmaceutical sales data from 2019 to 2023Audrey Huili Lim, Norazida Ab Rahman, Siti Nur Su'Aidah Nasarudin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 11, 2023
Real-world nirmatrelvir-ritonavir outpatient treatment in reducing hospitalization for high-risk patients with COVID-19 during Omicron BA.4, BA.5 and XBB subvariants dominance in Malaysia: A retrospective cohort studyEe Vien Low, Mohan Dass Pathmanathan, Suresh Kumar Chidambaram, et al.
International Journal of Environmental Research and Public Health|March 11, 2023
Stigma, Sociodemographic Factors, and Clinical Factors Associated with Psychological Distress among COVID-19 Survivors during the Convalescence Period: A Multi-Centre Study in MalaysiaNur Iwana Abdul Taib, Nik Ruzyanei Nik Jaafar, Nazirah Azman, et al.
Drugs - Real World Outcomes|May 10, 2024
Economic Evaluation of Nirmatrelvir/Ritonavir Among Adults Against Hospitalization During the Omicron Dominated Period in Malaysia: A Real-World Evidence PerspectiveEe Vien Low, Hoon Shien Teh, Nicholas Yee Liang Hing, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open-Label Clinical TrialChuan Huan Chuah, Ting Soo Chow, Chee Peng Hor, et al.
The Lancet Regional Health. Western Pacific|March 29, 2021
Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in MalaysiaYuan Liang Woon, Yee Leng Lee, Yoong Min Chong, et al.
Travel Medicine and Infectious Disease|July 24, 2021
Diagnostic accuracy of fresh drooled saliva for SARS-CoV-2 in travelersAlif Adlan Mohd Thabit, Kalaiarasu M Peariasamy, Pei Xuan Kuan, et al.
JAMA Internal Medicine|February 18, 2022
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical TrialSteven Chee Loon Lim, Chee Peng Hor, Kim Heng Tay, et al.
Pageof 2